LGND Nov 2024 75.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:21PM EDT. Market open.
| Previous close | 10.74 |
| Open | 10.74 |
| Bid | 9.60 |
| Ask | 13.70 |
| Strike | 75.00 |
| Expiry date | 2024-11-15 |
| Day's range | 10.74 - 10.74 |
| Contract range | N/A |
| Volume | |
| Open interest | 53 |
ZacksShattuck (STTK) Announces Positive Interim Data on Cancer Drug
Shattuck (STTK) will now focus on higher-risk myelodysplastic syndromes and TP53 mutant acute myeloid leukemia indications for lead candidate SL-172154, following encouraging interim data from the phase IB dose expansion study.
ZacksBristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
The FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric patients aged 12 years and older with solid tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion.
ZacksWhat Makes Ligand (LGND) a New Strong Buy Stock
Ligand (LGND) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
© 2024 Yahoo. All rights reserved.